Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention
Condition: Sars-CoV2 Interventions: Drug: Lovenox 40 MG in 0.4 mL Prefilled Syringe; Device: Ultrasound of the lower limbs Sponsors: Centre Hospitalier Universitaire de Saint Etienne; CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials